Showing 81 - 100 results of 65,382 for search '(((( 5 c decrease ) OR ( 5 ht decrease ))) OR ( 5 ((ng decrease) OR (a decrease)) ))', query time: 1.09s Refine Results
  1. 81

    Design, Synthesis, and Biological Evaluation of New Peripheral 5HT<sub>2A</sub> Antagonists for Nonalcoholic Fatty Liver Disease by Minhee Kim (1592440)

    Published 2020
    “…Here, structural modifications of pimavanserin (CNS drug), a 5HT<sub>2A</sub> antagonist approved for Parkinson’s disease, led us to synthesize new peripherally acting 5HT<sub>2A</sub> antagonists. …”
  2. 82
  3. 83
  4. 84

    Table_1_Sub-Acute Treatment of Curcumin Derivative J147 Ameliorates Depression-Like Behavior Through 5-HT1A-Mediated cAMP Signaling.DOCX by Jianxin Li (158332)

    Published 2020
    “…These effects might be mediated by 5-HT<sub>1A</sub>-dependent cAMP/PKA/pCREB/BDNF signaling.…”
  5. 85
  6. 86
  7. 87
  8. 88
  9. 89
  10. 90
  11. 91
  12. 92
  13. 93
  14. 94

    Video_5_Contribution of 5-HT2 Receptors to the Control of the Spinal Locomotor System in Intact Rats.WMV by Henryk Majczyński (830716)

    Published 2020
    “…Little is known about the role of 5-HT receptors in the control of voluntary locomotion, so we administered inverse agonists of 5-HT<sub>2</sub> (Cyproheptadine; Cypr), 5-HT<sub>2A</sub> neutral antagonist (Volinanserin; Volin), 5-HT<sub>2C</sub> neutral antagonist (SB 242084), and 5-HT<sub>2B/2C</sub> inverse agonist (SB 206553) receptors intrathecally in intact rats and monitored their effects on unrestrained locomotion. …”
  15. 95
  16. 96
  17. 97

    Nimodipine does not decrease markers of neuritic dystrophy in 5XFAD transgenic mice. by Katherine R. Sadleir (12035242)

    Published 2022
    “…<p><b>(</b>A and F) Representative immunoblots of hippocampal (A) and cortical (F) lysates of non-transgenic and 5XFAD mice treated with vehicle or nimodipine. …”
  18. 98
  19. 99
  20. 100